Gong, Jun
Reimers, Melissa A.
Funding for this research was provided by:
Cedars-Sinai Medical Center
Article History
Received: 30 January 2024
Accepted: 6 June 2024
First Online: 18 July 2024
Declarations
:
: Dr Gong reports consultancy or advisory roles for Astellas Pharma, Aveo, Basilea Pharmaceutica, Bayer, Eisai, Elsevier, EMD Serono, Exelixis, HalioDx, Incyte, Janssen, Myovant, Natera, Pfizer, QED Therapeutics, and Seagen. Dr Reimers reports institutional research funding from AstraZeneca, Bristol Myers Squibb, CRISPR Therapeutics, Eisai, Exelixis, Forma, Genentech, Janssen, Loxo, Merck & Co., Kenilworth, NJ, and ProFoundBio; and consultancy or advisory roles for Loxo and Pathos AI.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.